The use of a hepatobiliary iminodiacetic acid (HIDA) scan to rule out biliary atresia, combined with confirmatory genetic testing that identified a mutation in the ABCB11 gene, exemplifies the critical role of advanced diagnostic tools in establishing a definitive diagnosis. The gene discussed is ABCB11; the disease is biliary atresia.